-
Medway NHS Foundation Trust to Transform Local Gestational Diabetes Screening by Offering World-First Home Oral Glucose Tolerance Testing (OGTT) Technology to All At-Risk Women
Biotech Newswire
July 22, 2024
Digostics and Medway NHS Foundation Trust announced a partnership that will see the Trust become the latest maternity services provider to extend new remote OGTT to all expectant mothers who are at risk of developing gestational diabetes mellitus .
-
The Dynamic Diabetes and Metabolic Disorder Treatment Landscape
Daivd Orchard Webb/PharmaSources
July 03, 2023
Diabetes is a chronic medical condition characterized by high levels of glucose in the blood.
-
Research Progress of Glucose Sensitive Insulin Smart Drug Delivery System
PharmaSources/Xiao Ni Sha
December 10, 2021
Diabetes is one of the major social health problems in the world. Subcutaneous injection of insulin is the traditional administration in the diabetes treatment, which is inconvenient and painful.
-
Global Diabetes Market Outlook
Dr. Preet Pal S.B.
November 22, 2021
Diabetes is a well-known metabolic disorder, and the number of people living with it continues to rise. Although it is a segment of opportunity for pharmaceutical manufacturers, understanding it is complex.
-
Chinese Developed New Drug Exploits the Field of Diabetes
PharmaSources/Yi
November 01, 2021
Recently, the marketing application of chiglitazar sodium tablets, a new type 1 drug of Chipscreen (the relevant acceptance No. is CXHS1900032), has entered the administrative examination and approval stage, and it is expected that...
-
Good News in the Chinese Diabetes Field and Several Original Research Drugs Underway
PharmaSources/Dopine
May 25, 2021
Glad tidings came recently in terms of supervision of two domestic diabetes drugs. Semaglutide, Novo Nordisk's blockbuster hypoglycemic drug, advanced to the administrative approval stage (acceptance number: JXSS2000005/6) on April 20.
-
Centralized procurement cuts insulin prices, benefits millions of diabetes patients
www.gov.cn
April 22, 2023
China's diabetes patients now have access to high-quality and more affordable insulin products, as the country's drug bulk-buying program for insulin products has led to an average price cut of 48 percent.
-
Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment
PharmaSources.com
March 25, 2022
Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment.
-
Hua Medicine Announces 2021 Annual Results
PharmaSources.com
March 17, 2022
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period").
-
Winter Weather Can Bring Dry, Cracked Heels. Expert Offers Help
drugs.com
February 13, 2022
Dry, cracked heels are common in the winter, but there are several ways to prevent and treat the problem, a skin specialist says.